2-Aminopyridine

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	2-Aminopyridine SCHEMBL2775240	0.92	—	—
	2-Aminopyridine SCHEMBL9064720	0.92	NOS3 (1.00)	NOS3NOS1NOS2PI4KAPI4K2B
	2-Aminopyridine SCHEMBL17844	0.92	—	—
	2-Aminopyridine SCHEMBL29392931	0.92	—	—
	2-Aminopyridine SCHEMBL15012466	0.89	—	—
	2-Aminopyridine SCHEMBL20496124	0.89	—	—
	2-Aminopyridine SCHEMBL4938381	0.89	—	—
	2-Aminopyridine SCHEMBL70318	0.89	—	—
	2-Aminopyridine SCHEMBL8135890	0.89	NOS3 (0.94)	NOS3NOS1NOS2PI4KAPI4K2B
	2-Aminopyridine SCHEMBL2333406	0.89	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.